Literature DB >> 22174097

Experts do not agree when to treat retinopathy of prematurity based on plus disease.

Carina Slidsborg1, Julie Lyng Forman, Alistair R Fielder, Sven Crafoord, Kirsten Baggesen, Regitze Bangsgaard, Hans Callø Fledelius, Gorm Greisen, Morten la Cour.   

Abstract

OBJECTIVES: To investigate inter-reader agreement on five severity levels of central vascular changes (none, mild, moderate, severe pre-plus disease, plus disease) and aggressive posterior retinopathy of prematurity (ROP), and to see whether an unintended shift in indication for treatment occurred.
METHODS: Four international ROP readers participated. Before the grading of the photographs, the readers were informed that a high proportion of advanced ROP cases were included. In total, 243 photographs/948 quadrants were available from 136 infants. As a standard series of photographs was available, grading was performed under optimised conditions.
RESULTS: The four readers agreed on the quadrant scores of only 70 (7.38%) of the 948 quadrants--that is, on 1, 5, 15, 4 and 45 quadrants for scores 0, 1, 2, 3 and 4, respectively. The mean scores differed systematically between the readers (permutation test, p<0.0001). Agreement on presence of aggressive posterior ROP from all four readers was not obtained for any of the photographs. Readers scored plus disease in at least two quadrants in 95.5% of the eyes for which treatment was indicated. All four readers agreed on the scoring of indication for treatment for 195 eyes (80.2%); however, treatment was only recommended in 18 (7.4%) eyes. One reader was found to differ systematically from the others in indicating treatment (Rasch analysis; p=0.0001). Finally, a significant shift in indication for treatment occurred between birth period 2000-2002 and 2003-2006 (Mann-Whitney rank sum test, p<0.001).
CONCLUSIONS: Inter-reader agreement on central vascular changes is poor, especially when based on more than two rating categories. The subjective nature of diagnosing such vascular changes possibly resulted in earlier treatment of preterm infants in Denmark over the entire study period (1997-2006). The recent increased incidence of treated infants in Denmark is, at least in part, explained by a significant shift in indication for treatment.

Entities:  

Mesh:

Year:  2011        PMID: 22174097     DOI: 10.1136/bjophthalmol-2011-300573

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  21 in total

1.  Plus Disease in Retinopathy of Prematurity: Diagnostic Trends in 2016 Versus 2007.

Authors:  Chace Moleta; J Peter Campbell; Jayashree Kalpathy-Cramer; R V Paul Chan; Susan Ostmo; Karyn Jonas; Michael F Chiang
Journal:  Am J Ophthalmol       Date:  2017-01-11       Impact factor: 5.258

Review 2.  Retinopathy of prematurity.

Authors:  Ann Hellström; Lois E H Smith; Olaf Dammann
Journal:  Lancet       Date:  2013-06-17       Impact factor: 79.321

3.  It is time to bring retinopathy of prematurity monitoring into the 21st century.

Authors:  Michael T Trese
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-04       Impact factor: 3.117

4.  Dealing with inter-expert variability in retinopathy of prematurity: A machine learning approach.

Authors:  V Bolón-Canedo; E Ataer-Cansizoglu; D Erdogmus; J Kalpathy-Cramer; O Fontenla-Romero; A Alonso-Betanzos; M F Chiang
Journal:  Comput Methods Programs Biomed       Date:  2015-06-16       Impact factor: 5.428

5.  Aggressive posterior retinopathy of prematurity: a pilot study of quantitative analysis of vascular features.

Authors:  Rany Woo; R V Paul Chan; Anand Vinekar; Michael F Chiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-21       Impact factor: 3.117

Review 6.  Plus Disease in Retinopathy of Prematurity: More Than Meets the ICROP?

Authors:  Layla Ghergherehchi; Sang Jin Kim; J Peter Campbell; Susan Ostmo; R V Paul Chan; Michael F Chiang
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2018-05-24

7.  Single grading vs double grading with adjudication in the telemedicine approaches to evaluating acute-phase retinopathy of prematurity (e-ROP) study.

Authors:  Ebenezer Daniel; Wei Pan; Graham E Quinn; Eli Smith; Agnieshka Baumritter; Gui-Shuang Ying
Journal:  J AAPOS       Date:  2017-12-20       Impact factor: 1.220

8.  Facilitated Versus Self-guided Training of Non-ophthalmologists for Grading Pre-plus and Plus Disease Using Fundus Images for Retinopathy of Prematurity Screening.

Authors:  Nikolas N Raufi; Caleb K Morris; Sharon F Freedman; David K Wallace; S Grace Prakalapakorn
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2016-05-01       Impact factor: 1.402

9.  Variability in Plus Disease Identified Using a Deep Learning-Based Retinopathy of Prematurity Severity Scale.

Authors:  Rene Y Choi; James M Brown; Jayashree Kalpathy-Cramer; R V Paul Chan; Susan Ostmo; Michael F Chiang; J Peter Campbell
Journal:  Ophthalmol Retina       Date:  2020-05-04

10.  A murine model for retinopathy of prematurity identifies endothelial cell proliferation as a potential mechanism for plus disease.

Authors:  Victor H Guaiquil; Nina J Hewing; Michael F Chiang; Mark I Rosenblatt; R V Paul Chan; Carl P Blobel
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-07       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.